Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    75.00 (1.38%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Disposal

5 Dec 2024 07:00

RNS Number : 8817O
Camellia PLC
05 December 2024
 

 

Camellia Plc

Update on sale of BF&M shares

5 December 2024

Camellia Plc (the "Company") is pleased to announce that the regulatory and tax approvals required in connection with the proposed sale of its shares in BF&M Limited to Bermuda Life Insurance Company Limited, a subsidiary of Argus Group Holdings Limited, have been received and the sale is anticipated to complete imminently ("Completion"). At Completion, the Company expects to receive the full gross consideration of $100 million in cash. Net proceeds are expected to be c.$99.5 million (c.£78.7 million) and the transaction will crystalise a net profit of c.£10.7 million including accumulated exchange gains and losses. The Company will update shareholders on the use of funds upon receipt of the net proceeds from the sale.

 

ENQUIRIES 

 

Camellia Plc

01622 746655

Byron Coombs Chief Executive Officer

 

Oliver Capon, Chief Financial Officer

 

 

 

Panmure Liberum

020 7886 2500

Nominated Adviser and Broker

 

Emma Earl

 

Rupert Dearden

 

 

 

H/Advisers Maitland 

07785 292617

PR

 

William Clutterbuck

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISTIBTTMTAMTAI
Date   Source Headline
1st Aug 200510:21 amRNSEPT Disclosure
27th Jul 200510:30 amRNSEPT Disclosure
26th Jul 200511:05 amRNSEPT Disclosure
20th Jul 200510:35 amRNSEPT Disclosure
18th Jul 200510:29 amRNSEPT Disclosure
7th Jul 200511:16 amRNSEPT Disclosure
17th Jun 200510:40 amRNSEPT Disclosure
13th Jun 20056:00 pmRNSEPT Disclosure
7th Jun 20051:00 pmRNSAGM Statement
7th Jun 200510:50 amRNSStatement re possible offer
7th Jun 200510:50 amRNSStatement re possible offer
9th May 20052:00 pmRNSReport and accounts 2004
28th Apr 20053:04 pmRNSFinal Results
31st Mar 20054:01 pmRNSEACP
17th Feb 20052:01 pmRNSAcquisition
3rd Feb 200512:17 pmRNSEACP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.